CRYO-CELL International, Inc.

NYSE : CCEL

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases. The company manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.

Information

Sector
Healthcare
Industry
Medical Care Facilities
Type
Common Stock
Country
United States

Price

USD 6.48

Symbol

CCEL

Type

Common Stock

Previous Close

:

6.53

52 Week Range

:

3.67 - 9.50

Volume

:

724.00

Average Volume

:

4,512.00

High

:

6.74

Low

:

6.17

Change

:

-0.05

Percent change (%)

:

-0.77

Disclaimer: Stakeville is a simulation trading game. All trades and stock prices are fictional and do not reflect real-world markets. This game is for entertainment purposes only and does not involve real financial transactions. Read more...